FDA Inspection
Tedor Pharma, Inc.Tedor Pharma, Inc. – FDA Inspection, Apr 20, 2017
Record Details
This FDA Inspection record concerns Tedor Pharma, Inc., with an inspection on April 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6d50ae4a-31d4-4a0a-a156-4831edc01911
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1010372
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tedor Pharma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | VAI | New England District Office | Drug Quality Assurance |
| January 31, 2019 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| October 29, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tedor Pharma, Inc.
- FDA Inspection 1271887 - 2025-06-05
- FDA Inspection 1077786 - 2019-01-31
- FDA Inspection 853221 - 2013-10-29
- FDA Inspection 743987 - 2011-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.